Tempus AI, Inc. (NASDAQ:TEM) Shares Acquired by Avanza Fonder AB

Avanza Fonder AB boosted its holdings in Tempus AI, Inc. (NASDAQ:TEM) by 15.8% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 41,005 shares of the company’s stock after acquiring an additional 5,591 shares during the period. Avanza Fonder AB’s holdings in Tempus AI were worth $2,047,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Operose Advisors LLC purchased a new position in shares of Tempus AI during the 4th quarter worth approximately $25,000. Farther Finance Advisors LLC acquired a new position in Tempus AI during the fourth quarter worth $34,000. Prestige Wealth Management Group LLC boosted its position in shares of Tempus AI by 910.4% during the fourth quarter. Prestige Wealth Management Group LLC now owns 1,071 shares of the company’s stock worth $36,000 after buying an additional 965 shares during the period. NewEdge Advisors LLC acquired a new stake in shares of Tempus AI in the fourth quarter valued at $49,000. Finally, First Horizon Advisors Inc. lifted its stake in Tempus AI by 207.9% during the 4th quarter. First Horizon Advisors Inc. now owns 1,641 shares of the company’s stock worth $55,000 after acquiring an additional 1,108 shares in the last quarter. Hedge funds and other institutional investors own 24.22% of the company’s stock.

Analyst Ratings Changes

Several research firms have weighed in on TEM. Wolfe Research downgraded Tempus AI from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, February 26th. Guggenheim reissued a “buy” rating on shares of Tempus AI in a research note on Tuesday, February 25th. Morgan Stanley upped their target price on shares of Tempus AI from $60.00 to $65.00 and gave the stock an “overweight” rating in a research note on Friday, May 9th. BTIG Research initiated coverage on shares of Tempus AI in a report on Monday, April 21st. They set a “buy” rating and a $60.00 target price on the stock. Finally, Needham & Company LLC reiterated a “buy” rating and issued a $70.00 price objective on shares of Tempus AI in a research note on Wednesday, May 7th. Six research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $63.42.

Tempus AI Trading Up 2.0%

TEM opened at $70.78 on Thursday. The company has a debt-to-equity ratio of 8.17, a quick ratio of 2.55 and a current ratio of 2.69. Tempus AI, Inc. has a one year low of $22.89 and a one year high of $91.45. The company has a market cap of $12.25 billion and a P/E ratio of -9.07. The business’s 50-day simple moving average is $54.65 and its 200-day simple moving average is $52.33.

Tempus AI (NASDAQ:TEM) last announced its quarterly earnings results on Tuesday, May 6th. The company reported ($0.24) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.27) by $0.03. The business had revenue of $255.74 million during the quarter, compared to analyst estimates of $248.13 million. The firm’s revenue for the quarter was up 75.4% compared to the same quarter last year. As a group, equities research analysts expect that Tempus AI, Inc. will post -6.15 EPS for the current fiscal year.

Insider Activity

In related news, Director Wayne A.I. Frederick sold 3,000 shares of the company’s stock in a transaction dated Monday, March 31st. The stock was sold at an average price of $45.54, for a total value of $136,620.00. Following the completion of the sale, the director now directly owns 26,514 shares of the company’s stock, valued at $1,207,447.56. This represents a 10.16% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Andrew Polovin sold 13,135 shares of Tempus AI stock in a transaction that occurred on Tuesday, March 18th. The stock was sold at an average price of $45.98, for a total value of $603,947.30. Following the transaction, the executive vice president now directly owns 154,171 shares in the company, valued at approximately $7,088,782.58. This trade represents a 7.85% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 139,888 shares of company stock worth $7,938,111. Corporate insiders own 27.60% of the company’s stock.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.